Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 15, Number 3—March 2009

Dispatch

Hepatitis E Virus Antibodies in Patients with Chronic Liver Disease

Muslim Atiq, Norah J. Shire, Anna Barrett, Susan D. Rouster, Kenneth E. Sherman, and Mohamed T. ShataComments to Author 
Author affiliations: University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA (M. Atiq); University of Cincinnati College of Medicine, Cincinnati, Ohio, USA (N.J. Shire, A. Barrett, S.D. Rouster, K.E. Sherman, M.T. Shata)

Main Article

Table 2

Hepatitis E virus immunoglobulin G multivariable logistic regression results

Risk factor Adjusted odds ratio SEM p value 95% Confidence interval
Age 1.05 0.02 0.002 1.02–1.09
Male gender 2.07 0.07 0.009 1.17–3.66
History of chronic liver disease 7.78 3.25 0.001 3.43–17.64

Main Article

Top of Page

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO